close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 4 Next >
ALS and the crushing cost of care: How 4 Americans face the 'bankruptcy disease'
Tags Biogen Inc Make It / Money Make It
From CNBC.com News
Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
Tags Biotech and Pharmaceuticals Biogen Inc Eli Lilly and Co
From CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
Tags Takeda Pharmaceutical Co Ltd Bristol/Myers Squibb Co Roche Holding AG
From CNBC.com News
FDA taps biotech industry veteran as RFK Jr.'s top drug regulator
Tags Social issues Health & Science Sarepta Therapeutics Inc
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags Amgen Inc Markets LILLY DRN
From CNBC.com News
Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
Tags Breaking News: Earnings Biotechnology Health & Science
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Politics Business Investment strategy
From CNBC.com News
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Tags Biotechnology Health & Science Bristol/Myers Squibb Co
From CNBC.com News
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
Tags Health care industry Earnings Pharmaceuticals
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags Investing GSK plc New York Times Co
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Exxon Mobil Corp Delta Air Lines Inc Ford Motor Co
From CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
Tags TransDigm Group Inc Stock markets Micron Technology Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Technology Business News Politics
From CNBC.com News
Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
Tags Science Alzheimer's disease Biotechnology
From CNBC.com News
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
Tags Biotechnology Health & Science Breaking News: Earnings
From CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
Tags US: News Companies Biogen Inc
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Biogen Inc Companies Biotech and Pharmaceuticals
From CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
Tags Science Health & Science Biotechnology
From CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
Tags U/S/ Markets Investing stocks
From CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
Tags Mad Money Market Outlook Biogen Inc
From CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
Tags Biotech and Pharmaceuticals Companies Biogen Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Intel Corp Microsoft Corp Bristol/Myers Squibb Co
From CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
Tags Business News Business Eisai Co Ltd
From CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
Tags Health care industry Health & Science Eisai Co Ltd
From CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
Tags Pharmaceuticals Earnings Health care industry
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Tesla Inc Economy Coca/Cola Co
From CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
Tags Science Biotechnology Health & Science
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Pfizer Inc Biotechnology Health & Science
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Business News Technology Politics
From CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
Tags US: News Biogen Inc Companies
From CNBC.com News
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.